• Neurocrine Biosciences average price to free cash flow ratio for 2024 was 26.02, a 26.83% increase from 2023.
• Neurocrine Biosciences average price to free cash flow ratio for 2023 was 35.56, a 44.65% decline from 2022.
• Neurocrine Biosciences average price to free cash flow ratio for 2022 was 64.25, a 85.48% decline from 2021.

Price to free cash flow ratio can be defined as